Mark Deneau,
MD, MS
Languages Spoken: English
Dr. Deneau is active in all aspects of pediatric gastroenterology and endoscopy. His main areas of clinical expertise are: inflammatory bowel disease (IBD; ulcerative colitis and Crohn disease), neonates and infants with liver disease and short bowel syndrome, and the inpatient care of very ill and hospitalized patients.
Dr. Deneau is a member of the inflammatory bowel disease clinic. He has IBD himself, and has been down the same road as many of his patients, with a first-hand knowledge of what it is like to live with this problem and have surgery. He is not shy about sharing his personal experiences with his patients when helpful. He truly takes this disease to heart, and tries to make the lives of his IBD patients better.
Dr. Deneau created and directs a unique neonatal intensive care unit (NICU) gastroenterology clinic. Ill infants in the NICU, who often require months-long hospitalizations for complex bowel and liver diseases, are now seen by only one gastroenterologist for their entire stay in the hospital and after going home. This program helps facilitate better communication, gives families one familiar face who knows their child well, and most importantly, tries to get patients home faster.
Dr. Deneau takes a conservative and thoughtful approach to patient care, and tries to avoid invasive procedures and excessive testing when possible. His goal is to make gastrointestinal diseases and symptoms as small a part of his patient's day-to-day lives as possible.
Dr. Deneau is active in teaching and training medical students, pediatric residents, and fellows. He has won multiple teaching awards and brings this talent for communication to his patient care. He excels at making sure his patients and families understand their diagnoses, procedures and medications.
Dr. Deneau is active in clinical research of liver disease in patients with inflammatory bowel disease, especially primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). He is active in multiple quality improvement projects throughout the hospital to improve patient safety and lower costs of care for gastrointestinal diseases.
Clinical Locations
Eccles Primary Children’s Outpatient Services Building
801-213-3599
Primary Children's Hospital Outpatient Services at Riverton
801-212-3359
Board Certification and Academic Information
| Academic Departments | Pediatrics
-
Associate Professor (Clinical) |
| Academic Divisions | Pediatric Gastroenterology |
| Board Certification | American Board of Pediatrics (Pediatrics) American Board of Pediatrics (Sub: Pediatric Gastroenterology) |
Dr. Deneau is active in teaching and training medical students, pediatric residents, and fellows. He has won multiple teaching awards and brings this talent for communication to his patient care. He excels at making sure his patients and families understand their diagnoses, procedures and medications.
Dr. Deneau is active in clinical research of liver disease in patients with inflammatory bowel disease, especially primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). He is active in multiple quality improvement projects throughout the hospital to improve patient safety and lower costs of care for gastrointestinal diseases.
Academic Locations
Eccles Primary Children’s Outpatient Services Building
801-213-3599
Board Certification and Academic Information
| Academic Departments | Pediatrics
-
Associate Professor (Clinical) |
| Academic Divisions | Pediatric Gastroenterology |
| Board Certification | American Board of Pediatrics (Pediatrics) American Board of Pediatrics (Sub: Pediatric Gastroenterology) |
Education History
| Fellowship | University of Utah Pediatric Gastroenterology, Hepatology and Nutrition Fellow |
| Graduate Training | University of Utah Clinical Investigation M.S. |
| Residency | University of Utah General Pediatrics Resident |
| Professional Medical | Wayne State University Medicine M.D. |
| Undergraduate | Purdue University Electrical Engineering B.S. |
Selected Publications - Journal Articles
Journal Article
- Jaramillo C, Valentino P, Deneau M (7/1/2017). Update on Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlap Syndrome in Childhood. Curr Hepatol Rep, 2017(3).
- Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (3/15/2017). The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology, 66(2), 518-527.
- Sauberman LJ, Deneau M, Falcone RA, Murray KF, Ali S, Kohli R, Ekong UD, Valentino PL, Grossman AB, Rand EB, Jonas MM, Saeed SA, Kamath BM (12/15/2016). Hepatic Issues and Complications Associated with Inflammatory Bowel Disease. A Clinical Report from the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees. J Pediatr Gastroenterol Nutr, 64(4), 639-652.
- Lascurain L, Jensen MK, Holmen G, Guthery SL, Deneau M (2015). Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis. Inflamm Bowel Dis.
- Jimenez-Rivera C, Ling SC, Ahmed N, Yap J, Aglipay M, Barrowman N, Graitson S, Critch J, Rashid M, Ng VL, Roberts EA, Brill H, Dowhaniuk JK, Bruce G, Bax K, Deneau M, Guttman OR, Schreiber RA, Martin S, Alvarez F (2015). Incidence and Characteristics of Autoimmune Hepatitis. Pediatrics, 136(5), 1237-1248.
- Deneau M, Book LS, Guthery SL, Jensen MK (2014). Outcome after discontinuation of immunosuppression in children with autoimmune hepatitis: a population-based study. J Pediatr, 164(4), 714-719.e2.
- Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL (2013). Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology, 58(4), 1392-400.
- Deneau M, Mack C, Abdou R, Alqoaer K, Amir A, Auth M, Bazerbachi F, Broderick A, Chan A, DiGuglielmo M, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand F, Gupta N, Homan M, Jensen MK, Kim, KM, Kolho K, Konidari A, Koot B, Iorio R, Martinez M, Mohan P, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Vos M, Woynarowski M, Yap J, Miloh T (In Press). Gamma glutamyltransferase reduction leads to favorable long-term outcomes in pediatric primary sclerosing cholangitis. Hepatology Communications.
Abstract
- Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK (October 2016). The Natural History of Primary Sclerosing Cholangitis in 500 Children: A multicenter, international collaboration [Abstract]. Hepatology, 63(1), 72A.
- Ermarth A, Deneau M (2015). Clinical characteristics of very early onset inflammatory bowel disease: a population-based cohort [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), S22.
- Lascurain L, Deneau M (2015). Inflammatory bowel disease spares the poor but autoimmune hepatitis does not: socioeconomic factors in immune-mediated disease in Utah [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), S174.
- Ramakrishna Mutyala, Deneau M, Linda Book, Robin Kim, Ronald Day, M Kyle Jensen (2015). Frequency and Impact of Severe Hepatopulmonary Syndrome on Liver Transplantation in Children [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), S187.
- Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M Kyle Jensen, Deneau M (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration [Abstract]. Hepatology, 62(S1), 1038A.
- Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M Kyle Jensen, Deneau M (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), 184.
- Deneau M, Book L, Guthery SL, Jensen MK (2013). Sustained immunosuppression-free remission in pediatric autoimmune hepatitis: a population-based study [Abstract]. Hepatology, 58(S1).
Global Impact
Selected Provider Publications
Journal Article
Deneau M, Mack C, Abdou R, Alqoaer K, Amir A, Auth M, Bazerbachi F, Broderick A, Chan A, DiGuglielmo M, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand F, Gupta N, Homan M, Jensen MK, Kim, KM, Kolho K, Konidari A, Koot B, Iorio R, Martinez M, Mohan P, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Vos M, Woynarowski M, Yap J, Miloh T (In Press). Gamma glutamyltransferase reduction leads to favorable long-term outcomes in pediatric primary sclerosing cholangitis. Hepatology Communications.
Global Impact: Canada, France, Greece, Ireland, Italy, Japan, Korea, Poland, Slovenia, United Kingdom.Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (3/15/2017). The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology, 66(2), 518-527.
Global Impact: Canada, Czech Republic, Finland, France, Greece, Israel, Italy, Japan, Netherlands, Poland, Saudi Arabia, Slovenia, United Kingdom.Jimenez-Rivera C, Ling SC, Ahmed N, Yap J, Aglipay M, Barrowman N, Graitson S, Critch J, Rashid M, Ng VL, Roberts EA, Brill H, Dowhaniuk JK, Bruce G, Bax K, Deneau M, Guttman OR, Schreiber RA, Martin S, Alvarez F (2015). Incidence and Characteristics of Autoimmune Hepatitis. Pediatrics, 136(5), 1237-1248.
Global Impact: Canada.
Abstract
Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK (October 2016). The Natural History of Primary Sclerosing Cholangitis in 500 Children: A multicenter, international collaboration [Abstract]. Hepatology, 63(1), 72A.
Global Impact: Canada.Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M Kyle Jensen, Deneau M (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration [Abstract]. Hepatology, 62(S1), 1038A.
Global Impact: Canada.Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M Kyle Jensen, Deneau M (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), 184.
Global Impact: Canada.
Awards & Honors
| Young Investigator Research Award - European Association of the Study of the Liver (EASL) annual meeting | France |
| PSC Partners Seeking A Cure award for outstanding primary sclerosing cholangitis research - American Association for the Study of Liver Diseases Foundation 2017 | Canada |
Grand Rounds
| The Use and Misuse of Proton Pump Inhibitors. The Manitoba Institute of Child Health, John Buhler Research Centre, Winnipeg, Manitoba | Canada |
Presentations
| Natural history of pediatric primary sclerosing cholangitis. Trial Designs and Endpoints for Clinical Trial in Adults and Children with Primary Sclerosing Cholangitis. Joint workshop of the American Association for the Study of Liver Diseases (AASLD) and the U.S. Food and Drug Administration (FDA). March 3, 2016. Silver Spring, Maryland. | Canada |
Career
| University of Manitoba | Assistant Professor | Canada |